Lilly CEO bullish on momentum in 2023
This year is slated to be a big one for Indianapolis-based Eli Lilly and Co. as the pharmaceutical giant plans to release four new medicines to the public, with even more in the pipeline. CEO Dave Ricks said the momentum was created by tailwinds in 2022.... Read More